'It's not my greengrocer, it's someone from the medical profession': A qualitative study regarding acceptability of deceptive and open-label placebo prescribing in France.
Leo DruartOriana VauthrinNicolas PinsaultCosima LocherCharlotte R BleasePublished in: British journal of health psychology (2022)
Treatment acceptability by patients is a pre-requisite, alongside effectiveness, to harness OLPs in clinical care. Our study identified the importance of trust in HCPs prescribing placebos, the clinical effectiveness of placebos and the potential risks of these interventions in assessing their acceptability. Future research is needed to explore the contexts in which placebos might be used, and how best to communicate information about placebo interventions.
Keyphrases
- primary care
- open label
- randomized controlled trial
- healthcare
- end stage renal disease
- systematic review
- physical activity
- phase iii
- newly diagnosed
- ejection fraction
- chronic kidney disease
- health information
- clinical trial
- palliative care
- human health
- double blind
- adverse drug
- emergency department
- peritoneal dialysis
- study protocol
- risk assessment
- phase ii study
- pain management
- phase ii
- social media
- combination therapy
- chronic pain
- electronic health record
- health insurance
- drug induced